Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | September 04, 2024 |
| PDB ID | UniProt ID | Title | Descriptor ▲ |
|---|---|---|---|
| 8G3W | A0A4P1LXE0 | MBP-Mcl1 in complex with ligand 28 | |
| 8G3X | Q07820 | MBP-Mcl1 in complex with ligand 32 | |
| 8G3X | A0A4P1LXE0 | MBP-Mcl1 in complex with ligand 32 | |
| 8G3Y | Q07820 | MBP-Mcl1 in complex with ligand 34 | |
| 8G3Y | A0A4P1LXE0 | MBP-Mcl1 in complex with ligand 34 | |
| 8GHY | A0A1Y1V643 | Crystal Structure of the E154D mutant CelD Cellulase from the Anaerobic Fungus Piromyces finnis in the complex with cellotriose. | |
| 8HN7 | 8HN7 | Crystal structure of monoclonal antibody complexed with SARS-CoV-2 RBD | |
| 8HN7 | P0DTC2 | Crystal structure of monoclonal antibody complexed with SARS-CoV-2 RBD | |
| 8IDP | A0A0B8MZ29 | Crystal structure of reducing-end xylose-releasing exoxylanase in GH30 from Talaromyces cellulolyticus | |
| 8IDQ | A0A0B8MZ29 | Crystal structure of reducing-end xylose-releasing exoxylanase in GH30 from Talaromyces cellulolyticus with xylose | |
| 8IF2 | Q9BYF1 | Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron BQ.1.1 variant spike protein in complex with its receptor ACE2 | |
| 8IF2 | P0DTC2 | Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron BQ.1.1 variant spike protein in complex with its receptor ACE2 | |
| 7WT7 | P0DTC2 | SARS-CoV-2 Omicron variant spike in complex with Fab 9A8 (State 1) | |
| 7WT7 | 7WT7 | SARS-CoV-2 Omicron variant spike in complex with Fab 9A8 (State 1) | |
| 7WT8 | P0DTC2 | SARS-CoV-2 Omicron variant spike in complex with Fab 9A8 (State 2) | |
| 7WT8 | 7WT8 | SARS-CoV-2 Omicron variant spike in complex with Fab 9A8 (State 2) | |
| 7XTG | P0A311 | Cryo-EM structure of Listeria monocytogenes man-PTS complexed with pediocin PA-1 | |
| 7XTG | Q48864 | Cryo-EM structure of Listeria monocytogenes man-PTS complexed with pediocin PA-1 | |
| 7XTG | A0A094YUG1 | Cryo-EM structure of Listeria monocytogenes man-PTS complexed with pediocin PA-1 | |
| 7XTG | A0A094XZA1 | Cryo-EM structure of Listeria monocytogenes man-PTS complexed with pediocin PA-1 | |
| 7Y6D | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Delta variant spike proteins on intact virions: 3 Closed RBD | |
| 7YL5 | S6FKX6 | Cell surface protein YwfG protein complexed with mannose | |
| 7YL6 | S6FKX6 | Cell surface protein YwfG protein complexed with alpha-1,2-mannobiose | |
| 7YQG | A0A2U9GLY1 | Functional and Structural Characterization of Norovirus GII.6 in Recognizing Histo-blood Group Antigens | |
| 8AA0 | Q8A6W3 | Levan utilisation machinery (utilisome) with levan fructo-oligosaccharides DP 8-12 | |
| 8AA0 | Q8A6W4 | Levan utilisation machinery (utilisome) with levan fructo-oligosaccharides DP 8-12 | |
| 8AA0 | Q8A6W6 | Levan utilisation machinery (utilisome) with levan fructo-oligosaccharides DP 8-12 | |
| 8AA0 | Q8A6W5 | Levan utilisation machinery (utilisome) with levan fructo-oligosaccharides DP 8-12 | |
| 8AA1 | Q8A6W3 | Core SusCD transporter units from the levan utilisome with levan fructo-oligosaccharides DP 8-12 | |
| 8AA1 | Q8A6W4 | Core SusCD transporter units from the levan utilisome with levan fructo-oligosaccharides DP 8-12 | |
| 8AA2 | Q8A6W3 | Inactive levan utilisation machinery (utilisome) in the presence of levan fructo-oligosaccharides DP 15-25 | |
| 8AA2 | Q8A6W4 | Inactive levan utilisation machinery (utilisome) in the presence of levan fructo-oligosaccharides DP 15-25 | |
| 8AA2 | Q8A6W6 | Inactive levan utilisation machinery (utilisome) in the presence of levan fructo-oligosaccharides DP 15-25 | |
| 8AA2 | Q8A6W5 | Inactive levan utilisation machinery (utilisome) in the presence of levan fructo-oligosaccharides DP 15-25 | |
| 8AA3 | Q8A6W3 | Core SusCD transporter units from the inactive levan utilisome in the presence of levan fructo-oligosaccharides DP 15-25 | |
| 8AA3 | Q8A6W4 | Core SusCD transporter units from the inactive levan utilisome in the presence of levan fructo-oligosaccharides DP 15-25 | |
| 8B48 | A0A6G1IIU9 | Structure of Lentithecium fluviatile carbohydrate esterase from the CE15 family (LfCE15C) | |
| 8CXI | A0A142DS37 | Structures of Zika Virus in Complex with Antibodies Targeting E Dimer Epitopes and Basis for Neutralization Efficacy | |
| 8CXI | Q9H9E1 | Structures of Zika Virus in Complex with Antibodies Targeting E Dimer Epitopes and Basis for Neutralization Efficacy | |
| 8CXI | A0A1S6LXE0 | Structures of Zika Virus in Complex with Antibodies Targeting E Dimer Epitopes and Basis for Neutralization Efficacy | |
| 8CXI | 8CXI | Structures of Zika Virus in Complex with Antibodies Targeting E Dimer Epitopes and Basis for Neutralization Efficacy | |
| 8CYH | 8CYH | Novel Anti-Mesothelin Antibodies Enable Crystallography of the Intact Mesothelin Ectodo- main and Engineering of Potent, T cell-engaging Bispecific Therapeutics | |
| 8CYH | Q13421 | Novel Anti-Mesothelin Antibodies Enable Crystallography of the Intact Mesothelin Ectodo- main and Engineering of Potent, T cell-engaging Bispecific Therapeutics | |
| 8D55 | P0DTC2 | Closed state of SARS-CoV-2 BA.2 variant spike protein | |
| 8D56 | P0DTC2 | One RBD-up state of SARS-CoV-2 BA.2 variant spike protein | |
| 8D5A | P0DTC2 | Middle state of SARS-CoV-2 BA.2 variant spike protein | |
| 8DIS | 8DIS | CryoEM structure of Influenza A virus A/Melbourne/1/1946 (H1N1) hemagglutinin bound to CR6261 Fab | |
| 8EJD | P08669 | Structure of lineage IV Lassa virus glycoprotein complex (strain Josiah) | |
| 8EJE | E9K9S8 | Structure of lineage II Lassa virus glycoprotein complex (strain NIG08-A41) | |
| 8EJF | V9VG48 | Structure of lineage V Lassa virus glycoprotein complex (strain Soromba-R) |
